You are viewing an incomplete version of our website. Please click to reload the website as full version.
14th & 15th October 2013, Marriott Regents Park, London, UK

The 2nd Annual conference on Orphan Drugs & Rare Diseases 2013

Recent years have seen huge growth in orphan drug development, but also a time of increased pressure as many leading blockbuster drugs soon come off patent.

Join SMi for their 2nd Annual Orphan Drugs & Rare Diseases conference as they showcase world leading experts speaking inclusively on the orphan drug industry featuring cutting edge research via case studies taking place in previously untreatable patients. The conference will highlight current regulatory policies involving the FDA & EMA, new drug discoveries and partnerships in clinical trials and drug development with patient groups.


There will also be a 'big pharma spotlight session' highlighting where current pipelines stand and where the next blockbuster will be treating rare diseases, including discussions on HTA and pricing issues currently being implemented after recent reforms in Europe.


www.smi-online.co.uk/2013orphandrugs33.asp